Key result
Noninvasive diagnostic options and established cardiac safety monitoring protocols are essential for the early detection, prognosis, and management of chemotherapy-related cardiotoxicity.
This review outlines noninvasive diagnostic strategies and monitoring protocols for the early detection and management of chemotherapy-induced cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Supports cardiac monitoring in chemotherapy recipients; leaves open optimal noninvasive protocols pending prospective validation.
Gillespie et al. (2012) conducted a review in Chemotherapy-related cardiotoxicity. Noninvasive diagnostic options was evaluated. Noninvasive diagnostic options and established cardiac safety monitoring protocols are essential for the early detection, prognosis, and management of chemotherapy-related cardiotoxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: